VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
REGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
REGNRegeneron Pharmaceuticals, Inc.
$735.20$75.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksREGNQuarterly Cash Flow

Regeneron Pharmaceuticals, Inc. (REGN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Regeneron Pharmaceuticals, Inc. (REGN) quarterly cash flow statement — complete operating, investing & financing history

Income StatementBalance SheetCash FlowRatios

REGN Cash Flow Statement

Quarterly statement

REGN Cash Flow Statement

Regeneron Pharmaceuticals, Inc. (REGN) cash flow statement — 30-year operating, investing & financing cash flows

AnnualQuarterly
MetricQ2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21
Cash from Operations574.5M1.08B1.17B1.62B1.14B1.05B1.26B1.29B354M1.51B1.09B1.11B1.02B1.37B1.72B628.9M564.4M2.1B2.37B3.41B
Operating CF Margin %13.39%29.92%30.14%43.12%31.14%34.51%33.33%34.7%9.98%48.09%31.73%33.14%32.37%43.25%50.37%21.42%19.75%70.88%47.91%98.86%
Operating CF Growth %-49.8%3.23%-7.29%25.36%223.28%-30.9%15.89%15.88%-65.38%10.6%-36.64%77.18%81.15%-34.93%-27.51%-81.58%-9.94%214.39%92.73%1442.35%
Net Income1.3B727.2M844.6M1.46B1.39B808.7M917.7M1.34B1.43B722M1.16B1.01B968.4M817.8M1.2B1.32B852.1M973.5M2.23B1.63B
Depreciation & Amortization123.7M123.2M145M136.7M135.1M126.9M126.4M121.7M120.7M114.1M113M105.4M103.1M99.5M100.1M92.6M74.4M74.3M74.5M73.2M
Stock-Based Compensation243M257.4M249.3M237M251.7M255.7M304.4M225.1M223.2M230.1M240.4M203.9M202M238.7M232M166.3M159.8M166.9M188.4M136.9M
Deferred Taxes-194.4M-96M-232.5M-278.6M-135.2M-139.1M-280.2M-168.6M-118.1M-190.4M-286.3M-125.7M-209.3M-216.5M-279.7M-85.7M-156M-225M-205.9M7M
Other Non-Cash Items-733.6M144.5M158.4M-561.4M-270.9M-136.7M280.9M-695.6M-395.6M196.2M-75.6M115.2M39.5M187.2M88.4M-192.8M415.4M288.8M441.9M101.1M
Working Capital Changes-161.1M-77.4M5.9M625M-227.9M129.6M-86.4M468M-908.5M440.5M-61.4M-192.3M-81.3M240.9M382M-667.2M-781.3M823.2M-355.4M1.46B
Change in Receivables-838.5M1.2M-51.2M-80.3M-28.2M657.8M-117.8M-388.9M-494.1M446.8M-82.7M-463.5M-2.7M210.1M219.6M-386.9M-322.4M1.2B-584.5M1.54B
Change in Inventory-28.2M26.6M2.1M-82.6M-42.5M-152.3M-117.7M-164.4M-181.8M-155.8M-47.3M-77.2M-100.4M-46.8M-144.3M-223.5M-240.1M-88.6M-163.7M-109.1M
Change in Payables492.7M107.7M-24.7M759.2M216.4M-214.1M225.6M194.4M204.6M110.5M25.6M303.1M39.7M119M347.6M-160.3M-75.3M-250.4M365.7M76.7M
Cash from Investing-92.7M-428.9M220.3M-402.9M-1.09B647.5M350.6M-574.4M-557.2M-1.69B-66.2M-496.3M-2.39B-235.7M-1.86B192.3M-413.9M-1.71B-2.01B-2.44B
Capital Expenditures-240.2M-230.6M-290.7M-244.7M-406.8M-271.5M-267M-183.6M-210.9M-161.8M-313.5M-176M-113M-178.2M-152.2M-142.5M-153.6M-141.8M-154.9M-133.2M
CapEx % of Revenue5.6%6.4%7.48%6.52%11.07%8.96%7.05%4.93%5.95%5.14%9.13%5.23%3.58%5.64%4.46%4.85%5.38%4.78%3.13%3.86%
Acquisitions00-300K-3M00-11.5M-20.1M15.1M0-3.8M199.9M133.9M100.9M1.62B-1.26B-230.3M1.56B00
Investments--------------------
Other Investing-51M-48.9M00000-38.2M000-274.9M-154.8M-201.8M-1.72B334.8M0-1.56B00
Cash from Financing-2.34B-802.2M-780.1M-717.9M-1.13B-1.09B-1.14B-634M-478.1M47.1M-446.1M-407.3M-614.2M-322.5M-247.6M-725M-101.1M64.7M-906.6M385.4M
Debt Issued (Net)00000000000000000000
Equity Issued (Net)-1.12B-631.2M-168.2M-623.7M-1.03B-985.1M-882.1M-480.4M-166.3M390.8M12M-277.9M-598.1M-225.5M-58.5M-616.1M-52.2M163.5M-324.2M655M
Dividends Paid-96.8M-97.8M-92.7M-91.2M-92.6M-93.8M00000000000000
Share Repurchases-1.17B-794.3M-671.7M-664M-1.06B-1.05B-973M-735.1M-603.9M-291.3M-747.1M-675.9M-704.9M-807.7M-620.2M-1.04B-407.9M-456.9M-1.45B-436M
Other Financing-1.13B-73.2M-519.2M-3M-5.6M-10.3M-253.4M-153.6M-311.8M-343.7M-458.1M-129.4M-16.1M-97M-189.1M-108.9M-48.9M-98.8M-582.4M-269.6M
Net Change in Cash-1.86B-153.1M610.6M497.5M-1.08B604M477.2M83.6M-681.6M-128M577.6M210.5M-1.98B809.4M-385.4M96.2M49.4M461.1M-546.8M1.36B
Free Cash Flow334.3M848.3M922M1.42B967.6M773.6M995.8M1.11B143.1M1.35B776.2M938.3M909.4M1.19B1.57B486.4M410.8M1.96B2.22B3.28B
FCF Margin %7.79%23.53%23.74%37.75%26.32%25.54%26.28%29.77%4.03%42.95%22.6%27.9%28.8%37.61%45.91%16.57%14.38%66.1%44.78%95.01%
FCF Growth %-65.45%9.66%-7.41%27.96%576.17%-42.73%28.29%18.04%-84.26%13.56%-50.49%92.91%121.37%-39.31%-29.31%-85.17%-14.09%254.28%107.33%905.01%
FCF per Share3.137.888.5813.228.916.968.759.531.2411.746.828.277.9810.4313.754.313.6017.3319.5928.80
FCF Conversion (FCF/Net Income)0.44x1.48x1.39x1.11x0.82x1.29x1.38x0.96x0.25x2.09x0.94x1.11x1.06x1.67x1.44x0.48x0.66x2.16x1.06x2.09x
Interest Paid00000000000000000000
Taxes Paid00000000000000000000